Journal of patient-reported outcomes · 2026
Impact of facial telangiectasias and anemia on quality of life in patients with hereditary hemorrhagic telangiectasia: a cross-sectional study using FACE-Q.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Sadok Nadia, Bielefeld Franziska, Martin Carl Nikola, Skoda Eva-Marie, Klinger Katharina, Toppe Felicia, Schleupner Marie Carolin, Boosfeld Lukas, Kropf Björn, Voß Noemi, Lakomek Antonia, Valina Anna-Lena, Kaiser Christina, Garvert Julia, Lang Stephan, Droege Freya
Аннотация
BACKGROUND: Hereditary hemorrhagic telangiectasia (HHT) is an autosomal dominant disorder characterized by telangiectasias and visceral arteriovenous malformations. While the clinical manifestations are well described, its psychosocial impact-particularly with regard to visible facial telangiectasias and anemia-related appearance changes-remains insufficiently studied. This study aimed to assess appearance-related quality of life in individuals with hereditary hemorrhagic telangiectasia.
METHODS: In this cross-sectional, single-center study, adults with hereditary hemorrhagic telangiectasia were recruited at a specialized HHT center between November 2023 and May 2024. Participants completed validated patient-reported outcome measures, including the Facial Assessment and Cosmetic Enhancement (FACE-Q) questionnaire and the Patient-Reported Outcomes Measurement Information System (PROMIS-29 +2) profile. Besides that, a standardized questionnaire assessing demographic and clinical characteristics, subjective perceptions of pallor, and cosmetic disturbance was administrated. Disease severity was assessed using the Epistaxis Severity Score and the Toronto Severity Index. Analyses were performed for the overall cohort and stratified by sex to explore potential sex differences in health-related quality of life and symptom perception. Multivariate linear regression analyses were performed to identify independent predictors of FACE-Q subscale outcomes.
RESULTS: A total of 116 participants with HHT were included (mean age 60 ± 14 years; 62% were female). Subjective appearance perception showed strong effects: perceiving pallor or tiredness due to low hemoglobin levels was associated with greater appearance-related psychological distress (adjusted β = -9.09, 95% CI -17.23 to -0.94), whereas perceiving facial telangiectasias as cosmetically disturbing was associated with multiple appearance-related outcomes, including lower social function (adjusted β = -9.51, 95% CI -18.04 to -0.99), greater appearance-related psychological distress (adjusted β = -9.33, 95% CI -16.51 to -2.16), and lower satisfaction with the nose (adjusted β = -17.39, 95% CI -28.94 to -5.84). In contrast, objective clinical parameters and overall disease severity assessed by the Epistaxis Severity Score and the Toronto Severity Index were not independently associated with appearance-related quality of life.
CONCLUSIONS: In HHT, appearance-related quality of life is driven predominantly by subjective perception and psychosocial factors.
METHODS: In this cross-sectional, single-center study, adults with hereditary hemorrhagic telangiectasia were recruited at a specialized HHT center between November 2023 and May 2024. Participants completed validated patient-reported outcome measures, including the Facial Assessment and Cosmetic Enhancement (FACE-Q) questionnaire and the Patient-Reported Outcomes Measurement Information System (PROMIS-29 +2) profile. Besides that, a standardized questionnaire assessing demographic and clinical characteristics, subjective perceptions of pallor, and cosmetic disturbance was administrated. Disease severity was assessed using the Epistaxis Severity Score and the Toronto Severity Index. Analyses were performed for the overall cohort and stratified by sex to explore potential sex differences in health-related quality of life and symptom perception. Multivariate linear regression analyses were performed to identify independent predictors of FACE-Q subscale outcomes.
RESULTS: A total of 116 participants with HHT were included (mean age 60 ± 14 years; 62% were female). Subjective appearance perception showed strong effects: perceiving pallor or tiredness due to low hemoglobin levels was associated with greater appearance-related psychological distress (adjusted β = -9.09, 95% CI -17.23 to -0.94), whereas perceiving facial telangiectasias as cosmetically disturbing was associated with multiple appearance-related outcomes, including lower social function (adjusted β = -9.51, 95% CI -18.04 to -0.99), greater appearance-related psychological distress (adjusted β = -9.33, 95% CI -16.51 to -2.16), and lower satisfaction with the nose (adjusted β = -17.39, 95% CI -28.94 to -5.84). In contrast, objective clinical parameters and overall disease severity assessed by the Epistaxis Severity Score and the Toronto Severity Index were not independently associated with appearance-related quality of life.
CONCLUSIONS: In HHT, appearance-related quality of life is driven predominantly by subjective perception and psychosocial factors.